Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of the Mineralocorticoid Receptor in Microvascular Endothelial Dysfunction After Preeclampsia
NCT06749418Phase 1Recruiting
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of eplerenone in preeclampsia. Primary endpoints: Change in microvascular endothelial function following local eplerenone treatment compared to placebo treatment at Day 10 and Changes in 24-hour urine sodium at Day 9. Started Jan 2025; status: recruiting.
02
Drugs
eplerenone
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06749418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06749418.